Hel; Zdenek
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hel; Zdenek.The latest application filed is for "immunogenicity using a combination of dna and vaccinia virus vector vaccines".
- Hel; Zdenek - Rockville MD
- Hel, Zdenek - Birmingham AL
| Patent | Date |
|---|---|
| Immunogenicity Using A Combination Of Dna And Vaccinia Virus Vector Vaccines App 20100291037 - Franchini; Genoveffa ; et al. | 2010-11-18 |
| Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors Grant 7,771,729 - Franchini , et al. August 10, 2 | 2010-08-10 |
| Immunogenicity Using A Combination Of Dna And Vaccinia Virus Vector Vaccines App 20060240042 - Franchini; Genoveffa ; et al. | 2006-10-26 |
| Immunogenicity using a combination of DNA and vaccinia virus vector vaccines Grant 7,094,408 - Franchini , et al. August 22, 2 | 2006-08-22 |
| Novel chimeric rev, tat, and nef antigens App 20050019752 - Franchini, Genoveffa ; et al. | 2005-01-27 |
| Immunogenicity using a combination of dna and vaccinia virus vector vaccines App 20040033237 - Franchini, Genoveffa ; et al. | 2004-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 